COMPETING SUPPLEMENTAL APPLICATIONS: INNOVATIVE CANCER COMPLEMENTARY AND ALTERNATIVE MEDICINE INITIATIVE IN CANCER CENTERS: NOTICE OF LIMITED COMPETITION Release Date: August 11, 2000 NOTICE: CA-00-023 National Cancer Institute The National Cancer Institute (NCI) is announcing a limited competition for competing supplemental applications from NCI-designated Cancer Centers funded through P30 Cancer Center Support Grants. This supplemental initiative is intended to assist Cancer Centers in building a research capability in Cancer Complementary and Alternative Medicine research through provision of developmental funds for innovative pilot research projects having potential, ultimately, to compete for R01 support. The initiative is part of a continuing effort to stimulate and strengthen research in Cancer Complementary and Alternative Medicine in NCI-designated Cancer Centers as an important component of the broad research portfolio of the program as a whole. NCI-designated Cancer Centers possess the infrastructure, organization, leadership, and integrated multidisciplinary research objectives that enable them to build and incorporate new programs in emerging areas of cancer research. NCI staff will contact the current grantees directly regarding application procedures and format. INQUIRIES Inquiries are encouraged, and the opportunity to clarify issues and answer questions is welcome. Inquiries may be directed to: Phuong Thi Kim Pham, Ph.D. Program Director Office of Cancer Complementary and Alternative Medicine Office of the Deputy Director for Extramural Science National Cancer Institute National Institute of Health 6130 Executive Boulevard Suite 102 Rockville, MD 20852 U.S.A. Phone: 301-496-3866 Fax: 301-480-0075 e-mail: pp64n@nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||